Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations

Autor: Durgut S, Salihefendić L, Pećar D, Čeko I, Mulahuseinović N, Izmirlija M, Konjhodžić R

Publikováno v: Balkan Journal of Medical Genetics, Vol 26, Iss 2, Pp 21-26 (2024)

Almost 50% of NSCLC patients who initially show a successful response to tyrosine kinase inhibitors targeted therapy (TKI therapy) eventually develop acquired EGFR T790M mutation. The T790M secondary mutation can cause resistance to the targeted ther

Externí odkaz: https://doaj.org/article/0383d7a264dc474fb2a58625d8041d80

Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations.

Autor: Durgut, S¹ (AUTHOR) selma.durgut@agc.ba, Salihefendić, L¹ (AUTHOR), Pećar, D¹ (AUTHOR), Čeko, I¹ (AUTHOR), Mulahuseinović, N¹ (AUTHOR), Izmirlija, M² (AUTHOR), Konjhodžić, R^1,3 (AUTHOR)

Publikováno v: Balkan Journal of Medical Genetics. Dec2023, Vol. 26 Issue 2, p21-26. 6p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections.

Autor: Salihefendić L; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina., Čeko I; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina., Bešić L; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina., Mulahuseinović N; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina., Durgut S; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina., Pećar D; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina., Prnjavorac L; General Hospital Tešanj, Tešanj, Bosnia and Herzegovina., Kandić E; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina., Meseldžić N; Department of Pharmaceutical Biochemistry and Laboratory Diagnostics, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Bego T; Department of Pharmaceutical Biochemistry and Laboratory Diagnostics, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Prnjavorac B; General Hospital Tešanj, Tešanj, Bosnia and Herzegovina., Marjanović D; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.; Institute for Anthropological Research, University of Zagreb, Zagreb, Croatia., Konjhodžić R; ALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina., Ašić A; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.

Publikováno v: Frontiers in genetics [Front Genet] 2023 Aug 29; Vol. 14, pp. 1240245. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023).

Croatian genetic heritage: an updated Y-chromosome story.

Autor: Primorac D, Škaro V; Vedrana Škaro, Genos Ltd. DNA Laboratory, Borongajska cesta 83H, 10000 Zagreb, Croatia, vskaro@genos.hr., Projić P, Missoni S, Horjan Zanki I, Merkaš S, Šarac J, Novokmet N, Ledić A, Makar A, Lauc G, Anđelinović Š, Bašić Ž, Kružić I, Neuberg M, Smolić M, Smolić R, Hrstić I, Trivanović D, Konjhodžić R, Salihefendić L, Babić Jordamović N, Marjanović D

Publikováno v: Croatian medical journal [Croat Med J] 2022 Jun 22; Vol. 63 (3), pp. 273-286.